NASDAQ: TWST - Twist Bioscience Corporation

Yield per half year: +62.8%
Sector: Healthcare

Current price: 50.81 $
Average price: 6 $

Price according to DCF model (ebitda): -83.02 $ -263.4%
Price according to DCF model (FCF): -77.31 $ -252.16%
Price based on EPS: 45.39 $ -10.66%
Discount price Net Income: 123.59 $ +143.24%
Average analyst price: 21.33 $ -58.01%
2/10

Discounted Cash Flow (Based on EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -83.02 $
Current price = 50.81 $ (difference = -263.4%)


Data

Discounted Cash Flow (Based on FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -77.31 $
Current price = 50.81 $ (difference = -252.16%)


Data

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 45.39 $
Current price = 50.81 $ (difference = -10.66%)


Data

Discount price Net Income

Price = Fair cap / Count shares
Price - Fair price
Fair cap — fair capitalization
Count shares - Number of shares
Fair cap = Avg(P/E) * Discount Net Income(5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 123.59 $
Current price = 50.81 $ (difference = +143.24%)


Data

Average analyst price

Fair price = 21.33 $
Current price = 50.81 $ (difference = -58.01%)

Analyst Price forecast Changes Forecast date Expiration date
Barclays 26 $ -24.81 $ (-48.83%) 07.08.2023 06.08.2024
Goldman Sachs 20 $ -30.81 $ (-60.64%) 13.07.2023 12.07.2024